STEPHANIE SENFT: Open Payments
NPI 1861984072 · PALMYRA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,141 in 125 payments from 26 companies in 2025. Trend: 2023 $1,965 · 2024 $1,461 · 2025 $2,141
Food & beverage: $2,141
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 18 | $267 |
| Novo Nordisk Inc | 19 | $255 |
| AstraZeneca Pharmaceuticals LP | 9 | $216 |
| Lilly USA, LLC | 10 | $180 |
| Otsuka America Pharmaceutical, Inc. | 11 | $157 |
| ABBVIE INC. | 8 | $154 |
| PFIZER INC. | 14 | $146 |
| Astellas Pharma US Inc | 4 | $106 |
| Eisai Inc. | 3 | $94 |
| Teva Pharmaceuticals USA, Inc. | 4 | $71 |
Products named: TRELEGY ELLIPTA, REXULTI, Ozempic, Veozah, FARXIGA, Leqembi, MOUNJARO, Wegovy.
Industry payments across PA — which companies pay providers there.
